[A new indication for Sandimmum (cyclosporine A). Press release from Sandoz Laboratories].
D001855:Bone Marrow Diseases / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans
D016572:Cyclosporine
Une nouvelle indication pour Sandimmun (cyclosporine A). Communiqué des Laboratoires Sandoz.